These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 16227743

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
    Hirashima N.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700
    [Abstract] [Full Text] [Related]

  • 4. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma.
    Maluccio MA, Covey AM, Porat LB, Schubert J, Brody LA, Sofocleous CT, Getrajdman GI, Jarnagin W, Dematteo R, Blumgart LH, Fong Y, Brown KT.
    J Vasc Interv Radiol; 2008 Jun; 19(6):862-9. PubMed ID: 18503900
    [Abstract] [Full Text] [Related]

  • 5. Transcatheter partial splenic arterial embolization in patients with hypersplenism: a clinical evaluation as supporting therapy for hepatocellular carcinoma and liver cirrhosis.
    Hirai K, Kawazoe Y, Yamashita K, Kumagai M, Tanaka M, Sakai T, Inoue R, Eguchi S, Majima Y, Abe M.
    Hepatogastroenterology; 1986 Jun; 33(3):105-8. PubMed ID: 3017829
    [Abstract] [Full Text] [Related]

  • 6. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma--second report].
    Hirashima N, Itazu I, Nukaya H, Kimura H, Hasegawa I, Yoshimizu T, Nemoto S, Sakakibara K.
    Gan To Kagaku Ryoho; 1998 May; 25(6):873-9. PubMed ID: 9617326
    [Abstract] [Full Text] [Related]

  • 7. Hepatic perfusion index in evaluating treatment effect of transcatheter hepatic artery embolization in patients with hepatocellular carcinoma.
    Lin WY, Wang SJ, Yeh SH.
    Neoplasma; 1995 May; 42(2):89-92. PubMed ID: 7617083
    [Abstract] [Full Text] [Related]

  • 8. [The change of hepatic energy status after transcatheter arterial embolization (TAE) for hepatocellular carcinoma--a study using 31P-MRS].
    Taniguchi K, Kaminaga T, Sakon M, Umeshita K, Yamada T, Takeda Y, Higaki N, Aoki T, Ohzato H, Hasuike Y, Gotoh M, Murakami T, Nakamura H, Monden M.
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1632-4. PubMed ID: 9382494
    [Abstract] [Full Text] [Related]

  • 9. Effects of transcatheter hepatic arterial embolization on coagulation and fibrinolysis in patients with hepatocellular carcinoma.
    Sakon M, Kambayashi J, Taniguchi K, Yoshida T, Shiba E, Kawasaki T, Tsuji Y, Yukawa M, Murata K, Gotoh M.
    Am J Gastroenterol; 1991 Dec; 86(12):1800-3. PubMed ID: 1660219
    [Abstract] [Full Text] [Related]

  • 10. Serum interleukin 6 as a predicator of the therapeutic effect and adverse reactions after transcatheter arterial embolization.
    Yamazaki H, Nishimoto N, Oi H, Matsushita M, Ogata A, Shima Y, Inoue T, Tang JT, Yoshizaki K, Kishimoto T.
    Cytokine; 1995 Feb; 7(2):191-5. PubMed ID: 7780039
    [Abstract] [Full Text] [Related]

  • 11. [Hepatic artery embolization for primary hepatic carcinoma].
    Ye WJ.
    Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):151-3. PubMed ID: 2553366
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acute pancreatitis after transcatheter arterial embolization (TAE) for hepatocellular carcinoma.
    Kishimoto W, Nakao A, Takagi H, Hayakawa T.
    Am J Gastroenterol; 1989 Nov; 84(11):1396-9. PubMed ID: 2479261
    [Abstract] [Full Text] [Related]

  • 15. [Our initial experience with SMANCS in TAE for liver cancer].
    Fujita M, Inoue E, Kuroda C, Kasugai H, Sasaki Y, Nakano H, Imaoka S.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():105-8. PubMed ID: 9512697
    [Abstract] [Full Text] [Related]

  • 16. [Usefulness of caerulein in suppressing post-TAE complications of the gallbladder].
    Akamatsu K, Miyauchi S, Yasuhara Y, Mogami H, Nishimura N, Ohshima K, Ohta Y.
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1094-9. PubMed ID: 3032112
    [Abstract] [Full Text] [Related]

  • 17. Gelatin microspheres: initial clinical experience for the transcatheter arterial embolization.
    Nitta N, Ohta S, Tanaka T, Takazakura R, Nagatani Y, Kono N, Sonoda A, Seko A, Furukawa A, Takahashi M, Murata K, Tabata Y.
    Eur J Radiol; 2008 Sep; 67(3):536-40. PubMed ID: 17826023
    [Abstract] [Full Text] [Related]

  • 18. Emergency transcatheter embolization of ruptured hepatocellular carcinomas with tortuous conventional or aberrant hepatic vascular anatomy, or parasitic supply.
    Lau K, Wong WW, Chan JK, Kan WK, Leung JL, Lee AS, Lee LT, Lee GY.
    Australas Radiol; 2007 Apr; 51(2):190-5. PubMed ID: 17419870
    [Abstract] [Full Text] [Related]

  • 19. [Optimal size of embolic material in transcatheter arterial embolization of the liver].
    Sonomura T.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 May 25; 54(6):489-99. PubMed ID: 8028956
    [Abstract] [Full Text] [Related]

  • 20. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres.
    Osuga K, Hori S, Hiraishi K, Sugiura T, Hata Y, Higashihara H, Maeda N, Tomoda K, Nakamura H.
    Cardiovasc Intervent Radiol; 2008 May 25; 31(6):1108-16. PubMed ID: 18543028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.